Diagnostics Solutions Strategic Priorities
Roche Serum Work Area menu
Broadest menu on one integrated platform
Breadth of assay menu
250
231
200
IM¹
150
Launched in 2020 & upcoming launches in 2021
231
Immuno chemistry assays
HBsAg II Auto Conf
Androstenedione
Anti-SARS-CoV-2
Anti-SARS-CoV-2 S
SARS-CoV-2 Ag
IL6 (EUA)
EBV EBNA IgG
EBV VCA IgG
EBV IgM
Anti-p53
HCV Duo
GAAD
100
assays²
HIV Duo
CC
50
0
Roche cobasⓇ
SWA solutions
NT-proBNP claim extension4
TnT-hs claim extension4
PCT CE claim extension4
Vit D total ||4
Preeclampsia
Anti-HBe
Clinical chemistry assays
Kappa FLC3
ASTP24
Lambda FLC³
ALTP24
sdLDL3
fCal³
CRP4
A1MG3,4
Fentanyl³
Ethyl Glucuronide³
sTfR Gen 24
Benz 24
Sirolimus
Alzh CSF biomarkers
PIVKA II
On market
(Launched in 2020)
In development
(to be launched in 2021)
Roche
IM: Immunochemistry; CC: Clinical chemistry; 1 Not including confirmatory tests, stat tests and special assays in the allergy panel. Variants of the same assay (e.g. for HIV AG/Ab, different kit sizes)
are counted once; 2 Core unit| ISE |c 702 | c 702 | e 801 | e 801; 3 Partner Channel; 4 Product update
41View entire presentation